CellCept 250 Roche (Cellcept 250 mg)
Generic Name: mycophenolate mofetil
Pill imprint CellCept 250 Roche has been identified as Cellcept 250 mg.
CellCept is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. CellCept 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for CellCept 250 Roche (Cellcept 250 mg)
- Generic Name:
- mycophenolate mofetil
- 250 mg
- Orange & Turquoise
- 19.00 mm
- Prescription only
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Roche Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
FD&C Blue No. 2
ferric oxide yellow
ferric oxide red
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|68258-9073||Dispensing Solutions Inc. (repackager)|
|21695-0171||Rebel Distributors Corp (repackager)|
|49999-0936||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about CellCept (mycophenolate mofetil)
- CellCept capsules
- CellCept solution
- CellCept suspension
- Cellcept (Advanced Reading)
- Cellcept Oral (Advanced Reading)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...